DIVD - ETF AI Analysis

Top Page

Altrius Global Dividend ETF Altrius Global Divid ETF (DIVD)

Rating:70Neutral

Price Target:―

DIVD, the Altrius Global Dividend ETF, appears to be a solid, quality-focused fund, supported by strong holdings like Toyota, Novartis, AstraZeneca, and TotalEnergies, which bring robust financial performance, positive growth outlooks, and generally supportive technical trends. These strengths are partly offset by weaker names such as LyondellBasell, which faces revenue and profitability pressures, and BAE Systems, where bearish trading signals and a higher valuation add some caution. A key risk factor is that several major holdings show signs of potential overvaluation or overbought technical conditions, which could increase volatility if market sentiment shifts.

Positive Factors

Broad Sector Diversification

The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.

Generally Strong Top Holdings

Most of the largest positions have shown positive recent performance, which has supported the ETF’s overall returns.

Positive Recent Performance Trend

The ETF has delivered steady gains over the past month, three months, and year-to-date, indicating improving momentum.

Negative Factors

High U.S. Market Concentration

With the vast majority of assets in U.S. stocks, the fund is heavily tied to the performance of the U.S. market and offers limited global diversification.

Mixed Results Among Top Holdings

A few of the largest positions have shown weak or negative performance, which can drag on the fund if those stocks continue to lag.

Moderate Expense Ratio

The fund’s expense ratio is not especially low, meaning fees take a noticeable, ongoing bite out of investor returns compared with cheaper ETFs.

DIVD vs. SPDR S&P 500 ETF (SPY)

AUM16.03M

RegionGlobal

Expense Ratio0.49%

Beta0.59

IssuerAltrius

Inception DateSep 29, 2022

Dividend Yield2.82%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume2,052

30 Day Avg. Volume2,596

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

43.43

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering63

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DIVD Summary

DIVD, the Altrius Global Dividend ETF, focuses on high-dividend stocks from around the world, with most of its holdings in the U.S. and some in Europe. It does not track a specific index, but instead selects companies known for paying steady dividends across many sectors like health care, financials, and consumer staples. Well-known holdings include AstraZeneca and Roche. Someone might invest in DIVD to seek regular income from dividends while getting global diversification in one fund. A key risk is that stock prices and dividend payments can go up or down with the overall market and the global economy.

How much will it cost me?The Altrius Global Dividend ETF (DIVD) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 invested. This expense ratio is slightly higher than average for ETFs because it is actively managed, focusing on selecting global dividend-paying stocks rather than tracking a passive index.

What would affect this ETF?The Altrius Global Dividend ETF (DIVD) could benefit from global economic growth and increased demand for dividend-paying stocks, especially in sectors like Health Care and Consumer Defensive, which are known for stability and resilience. However, potential risks include rising interest rates, which may make dividend-focused investments less attractive, and geopolitical or regulatory challenges that could impact global markets and specific regions where the ETF is invested. Additionally, sector-specific issues, such as volatility in the Energy or Financial sectors, could negatively affect performance.

DIVD Top 10 Holdings

DIVD is leaning heavily on global health care and consumer staples, with names like GSK, AstraZeneca, and Novartis quietly powering the fund as their shares keep rising on solid drug pipelines and dependable dividends. Nestlé adds a steady, defensive backbone, even if its growth story looks a bit tired. On the cyclical side, Toyota and Ambev are giving the portfolio an extra boost, while LyondellBasell looks more like dead weight, with its weaker fundamentals threatening to trip up returns. Overall, it’s a globally diversified, dividend-first lineup with a tilt toward Europe and other non-U.S. markets.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
LYB	LyondellBasell	2.77%	$443.97K	$21.62B	-13.41%	52 Neutral
NSRGY	Nestle SA Reg	2.31%	$370.09K	$261.35B	1.96%	74 Outperform
TTE	TotalEnergies SE	2.30%	$368.13K	€145.45B	14.53%	78 Outperform
GSK	GlaxoSmithKline	2.30%	$368.10K	$109.49B	36.10%	77 Outperform
NVS	Novartis	2.26%	$362.11K	$302.10B	38.55%	80 Outperform
ETN	Eaton	2.25%	$360.11K	$134.89B	22.03%	75 Outperform
BP	BP	2.23%	$357.75K	$102.81B	26.10%	68 Neutral
BAESY	BAE Systems plc ADR	2.21%	$353.94K	$86.54B	46.10%	60 Neutral
AZN	AstraZeneca	2.20%	$352.18K	$301.48B	20.11%	80 Outperform
ABEV	Ambev SA	2.18%	$349.09K	$45.75B	30.94%	80 Outperform

DIVD Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price―

Price Trends

50DMA

40.73

Positive

100DMA

38.94

Positive

200DMA

37.23

Positive

Market Momentum

MACD

0.18

Positive

RSI

41.39

Neutral

STOCH

20.30

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVD, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 42.13, equal to the 50-day MA of 40.73, and equal to the 200-day MA of 37.23, indicating a neutral trend. The MACD of 0.18 indicates Positive momentum. The RSI at 41.39 is Neutral, neither overbought nor oversold. The STOCH value of 20.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DIVD.

DIVD Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DIVD	―	―	$16.03M	0.49%	70 Neutral
FDIV	―	―	$73.45M	0.35%	71 Outperform
DIVY	―	―	$29.54M	0.45%	70 Neutral
PAYR	―	―	$23.64M	0.40%	65 Neutral
DVGR	―	―	$14.04M	0.65%	72 Outperform
GENW	―	―	$4.39M	0.38%	70 Outperform

Performance Comparison

DIVD

Altrius Global Dividend ETF Altrius Global Divid ETF

40.95

6.96

20.48%

FDIV

MarketDesk Focused U.S. Dividend ETF

―

DIVY

Sound Equity Income ETF

―

PAYR

Federated Hermes Enhanced Income ETF

―

DVGR

DAC 3D Dividend Growth ETF

―

GENW

Genter Capital International Dividend ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents